{"nct_id":"NCT01883362","title":"Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML","status":"COMPLETED","status_verified_date":"2021-03","start_date":"2014-02-06","start_date_type":"ACTUAL","primary_completion_date":"2018-04-30","primary_completion_date_type":"ACTUAL","completion_date":"2018-04-30","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}